<?xml version="1.0" encoding="UTF-8"?>
<p id="para0018">From April 2013 to September 2018, a total of 67 patients who were hospitalized with laboratory-confirmed A(H7N9) virus infection were enrolled (Supplementary Fig. 1), including fourteen participants from the 2013 epidemic, forty-one from the 2013–2014 epidemic, and twelve from the 2016–2017 epidemic (Supplementary Fig. 2A). Eighteen patients were enrolled during hospitalization, four of them died in hospital and two were lost to follow-up. Forty-nine patients were recruited and followed only after hospital discharge. Serial visits after discharge were conducted at 1–5 months, 6–8 months, 12–13 months, and 65 months after disease onset for forty-nine patients from the 2013 and 2013–14 epidemics. A single visit was conducted at 16–20 months after illness onset for patients from the 2016–2017 epidemic. Numbers of participants and blood samples at different stages are shown in 
 <xref rid="fig0001" ref-type="fig">Fig. 1</xref> . A total of 128 serum samples were collected (Supplementary Fig. 2B), including one to seven specimens from each patient, and 33 patients provided at least two samples (
 <xref rid="tbl0001" ref-type="table">Table 1</xref> ).
</p>
